Breaking News

BASi Appoints CFO and Bioanalytical Ops VP

June 12, 2014

Jeffrey Potrzebowski has been appointed chief financial officer and James S. Bourdage, Ph.D., was named vice president Bioanalytical Operations at Bioanalytical Systems, Inc. (BASi).
Mr. Potrzebowski joins the company from Oerlikon Drive Systems, where he served as chief financial officer, responsible for the management and control of financial performance of the operating segment. Previously, he was senior vice president and chief financial officer of Remy International, a producer of electrical automotive parts with sales in excess of $1.2 billion.
Dr. Bourdage previously served as executive director of Biopharmaceutical CMC Solutions at Covance, responsible for the U.S. CMC operation. Prior to that, he was senior director of Bioanalytical Sciences at Pharmathene, Inc., a biodefense company. Dr. Bourdage was also global research advisor and team leader, Laboratory for Experimental Medicine at Eli Lilly Co., responsible for oversight of biotherapeutic immunogenicity and biomarker assay development to support global trials.
BASi president and chief executive officer, Jacqueline Lemke said, "These appointments represent significant steps forward in our continuing program to build a management team with the depth, experience and dedication to take BASi to the next level and achieve our goals for growth and profitability. Each of these senior executives brings an impressive record of accomplishment to his new role at BASi: Jeff Potrzebowski in financial management, reporting, planning and related public company CFO functions; and Jim Bourdage in the leadership and management of large global laboratory operations in the pharmaceutical and biotech industries. We welcome Jeff and Jim to BASi, and look forward to their contributions to our continued success."

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity